Patents by Inventor Vera Jankowski

Vera Jankowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220365083
    Abstract: The present invention relates to a method for diagnosing lupus nephritis in an individual suffering from systemic lupus erythematosus (SLE), said method conducted in vitro comprising identifying a protein that comprises an YB-1-like cold-shock domain which bears one or more guanidinylated lysinyl moieties (YB-1-G) in a sample S obtained from the individual. Furthermore, the present invention also refers to treating or preventing lupus nephritis in an individual, wherein lupus nephritis has been diagnosed in the individual by means of a method of the present invention.
    Type: Application
    Filed: October 7, 2020
    Publication date: November 17, 2022
    Applicant: Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
    Inventors: Ute RAFFETSEDER, Daniel BREITKOPF, Thomas RAUEN, Vera JANKOWSKI, Jürgen FLOEGE, Tammo OSTENDORF
  • Patent number: 11383010
    Abstract: The present invention relates to the use of a high-frequency electromagnetic field in method of dialysis where a dialyser is used for the exchange of substances, wherein the blood to be cleaned is exposed to a high-frequency electromagnetic field prior to and/or during contact with the dialyser, and to a dialysis machine for carrying out the use.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: July 12, 2022
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Joachim Jankowski, Walter Zidek, Falko Brettschneider, Vera Jankowski
  • Publication number: 20220096597
    Abstract: The present invention relates to a vasoconstriction-inhibiting factor (VIF) or a nucleic acid encoding it for the prevention and/or treatment of consequences of a heart disease. Furthermore, the present invention relates to pharmaceutical compositions containing the VIF and targeted (combination) therapies, in particular using the pharmaceutical compositions according to the invention. The present invention further relates to a kit for non-therapeutic in-vitro use containing the VIF or a nucleic acid encoding it.
    Type: Application
    Filed: February 5, 2020
    Publication date: March 31, 2022
    Inventors: Elisa-Anamaria LIEHN, Joachim JANKOWSKI, Vera JANKOWSKI
  • Publication number: 20170030929
    Abstract: The present invention relates to methods for diagnosing and/or monitoring the onset or progression of chronic kidney disease (CKD) in a patient by the analysis of post-translational modification of plasma proteins. The present invention provides improved means for diagnosing chronic kidney disease (CKD), and especially for the early recognition of CKD.
    Type: Application
    Filed: April 9, 2015
    Publication date: February 2, 2017
    Inventors: HORST-DIETER LEMKE, MARIEKE RÜTH, JOACHIM JANKOWSKI, VERA JANKOWSKI
  • Publication number: 20140246367
    Abstract: The present invention relates to the use of a high-frequency electromagnetic field in method of dialysis where a dialyser is used for the exchange of substances, wherein the blood to be cleaned is exposed to a high-frequency electromagnetic field prior to and/or during contact with the dialyser, and to a dialysis machine for carrying out said use
    Type: Application
    Filed: June 29, 2012
    Publication date: September 4, 2014
    Inventors: Joachim Jankowski, Walter Zidek, Falko Brettschneider, Vera Jankowski